Daiwa Securities Group Inc. Emergent Bio Solutions Inc. Transaction History

Daiwa Securities Group Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$33.11 - $55.01 $77,676 - $129,053	-2,346 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$50.07 - $66.05 $68,946 - $90,950	-1,377 Reduced 36.99%	2,346 $117,000
Q2 2021 Aug 06, 2021	SELL	$56.61 - $80.46 $31,475 - $44,735	-556 Reduced 12.99%	3,723 $235,000
Q1 2021 May 03, 2021	BUY	$86.23 - $125.19 $368,978 - $535,688	4,279 New	4,279 $398,000
Q4 2020 Feb 04, 2021	SELL	$79.17 - $111.47 $23,751 - $33,441	-300 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$81.91 - $134.94 $24,573 - $40,482	300 New	300 $31,000

168

36.3M

352K

770K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $485M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.